TABLE 1.
Patient group | No. of serum samples | No. (%) of samples seropositive for N. caninum
|
|||
---|---|---|---|---|---|
Concordant resultsa | Discordant resultsb | IBc | Totald | ||
HIV positive | 61 | 18 (30) | 9 (15) | 5 (8) | 23 (38)* |
Neurological disorders | 50 | 1 (2) | 11 (22) | 8 (16) | 9 (18)** |
Newborns | 91 | 1 (1) | 6 (7) | 4 (4) | 5 (5)† |
Control | 54 | 1 (2) | 5 (9) | 2 (4) | 3 (6)† |
Concordant results by ELISA and IFAT.
Discordant results by ELISA and IFAT.
Positive results by IB of sera with discordant results by ELISA and IFAT.
The total number of positive serum samples includes the number of samples with concordant results plus the number of serum samples with positive results by IB. Different symbols indicate statistically significant differences between the groups (P < 0.05).